Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,190,795
+$614,626 QoQ
Shares Held
12,680
+7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#1,611
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 29%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Bancorp, Inc. holds $17,238,730 across 16 Drug Manufacturers - General names. ABBV ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,700 | $6,836,751 | |
| 2 | JNJ |
Johnson & Johnson
|
16,748 | $4,253,489 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
12,680 | $3,190,795 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,566 | $1,229,231 | |
| 5 | NVS |
Novartis AG
|
3,551 | $556,512 | |
| 6 | PFE |
Pfizer Inc
|
21,473 | $517,069 | |
| 7 | AMGN |
Amgen Inc
|
487 | $176,352 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,289 | $131,892 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,190,795 | 12,680 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,576,169 | 11,845 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,722,686 | 11,916 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,767,134 | 11,951 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,249,343 | 12,118 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,613,552 | 12,474 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,306,723 | 12,981 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,586,198 | 13,096 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,257,889 | 13,164 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,526,091 | 13,872 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,149,743 | 13,872 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,139,309 | 14,352 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,937,686 | 14,382 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,218,430 | 13,920 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $2,211,794 | 13,686 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,951,279 | 14,539 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,202,134 | 14,378 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,437,161 | 15,034 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,986,318 | 14,670 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,572,528 | 14,578 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,544,181 | 13,709 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,473,848 | 13,619 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,437,524 | 13,416 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,193,501 | 13,626 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,343,986 | 13,689 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $1,042,964 | 13,689 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||